<- Go Home
Provexis plc
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through company’s website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Market Cap
GBP 14.7M
Volume
883.8K
Cash and Equivalents
GBP 708.1K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
GBP 532.9K
Profit Margin
41.24%
52 Week High
GBP 0.01
52 Week Low
GBP 0.00
Dividend
N/A
Price / Book Value
11.30
Price / Earnings
-31.41
Price / Tangible Book Value
11.30
Enterprise Value
GBP 13.4M
Enterprise Value / EBITDA
N/A
Operating Income
-GBP 452.0K
Return on Equity
94.87%
Return on Assets
-37.41
Cash and Short Term Investments
GBP 708.1K
Debt
N/A
Equity
GBP 763.8K
Revenue
GBP 1.3M
Unlevered FCF
-GBP 168.7K
Sector
Personal Care Products
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium